
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.510 | 0.510 | 0.000 |
Shares | 99.490 | 99.490 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.175 | 18.758 |
Price to Book | 3.337 | 3.074 |
Price to Sales | 2.216 | 2.290 |
Price to Cash Flow | 11.456 | 12.204 |
Dividend Yield | 1.675 | 2.034 |
5 Years Earnings Growth | 10.774 | 9.715 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.990 | 24.567 |
Financial Services | 16.490 | 16.878 |
Healthcare | 11.080 | 12.037 |
Communication Services | 9.560 | 8.153 |
Industrials | 9.150 | 12.149 |
Consumer Cyclical | 7.620 | 10.303 |
Consumer Defensive | 4.920 | 7.262 |
Real Estate | 4.020 | 2.763 |
Utilities | 2.710 | 2.533 |
Basic Materials | 2.460 | 3.923 |
Number of long holdings: 167
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 7.02 | 174.18 | -3.32% | |
Microsoft | US5949181045 | 6.79 | 506.69 | -0.58% | |
Apple | US0378331005 | 5.52 | 232.14 | -0.18% | |
Alphabet A | US02079K3059 | 2.28 | 212.91 | +0.60% | |
Mastercard | US57636Q1040 | 2.20 | 595.29 | +0.81% | |
Alphabet C | US02079K1079 | 2.07 | 213.53 | +0.55% | |
Novartis | CH0012005267 | 1.74 | 101.16 | -0.37% | |
TE Connectivity | IE000IVNQZ81 | 1.74 | 206.50 | -0.74% | |
Linde PLC | IE000S9YS762 | 1.39 | 410.000 | -0.24% | |
Eli Lilly | US5324571083 | 1.30 | 732.58 | +0.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0461105529 | 3.19B | -3.24 | 10.83 | 11.32 | ||
LU2403432821 | 3.19B | 5.86 | 13.25 | - | ||
LU1819524072 | 380.37M | -0.65 | 3.33 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review